An 11 year old’s story of taking part in immunotherapy research: Mahn was diagnosed with type 1 diabetes in May 2020. His parents Sharon and Harj were determined to get him onto a clinical trial testing a new treatment called immunotherapy, which hopes to slow the immune attack behind type 1 diabetes. Please click the link to Mahn’s story where he shares his experience of his diagnosis, treatments and life with diabetes.
https://type1diabetesresearch.org.uk/wp-content/uploads/2020/12/Mahn4_resized_2.jpg11051512sopnzhttp://www.type1diabetesresearch.org.uk/wp-content/uploads/2016/11/T1DUK-logo.pngsopnz2020-12-16 11:57:162021-08-25 14:03:06Mahn’s story: taking part in immunotherapy research
Scientists and researchers are hoping to slow down the progression or prevent type one diabetes with immunotherapy treatments. This thought-provoking article from DUK’s Balance magazine explains how immunotherapy can help fight type 1 diabetes.
Delaying type 1 diabetes: an exciting breakthrough has been made by scientists in the trial of an immunotherapy drug that has been shown to delay a diagnosis of type 1 diabetes.
We have two exciting agendas lined up for our Consortium meetings being held at the DUK conference in Liverpool on 5th and 6th March.
All scientists from the Consortium are getting together on 5th March for an interesting day of reporting developments in type 1 diabetes research in the UK.
On Wednesday evening the annual meeting for all Consortium sites that recruit patients into clinical trials will take place. This will include representatives from the pharmaceutical industry and is a great opportunity for our researchers to join together and reflect on achievements and plan for future trials.
https://type1diabetesresearch.org.uk/wp-content/uploads/2019/03/IMG_0472.jpg1200900sopnzhttp://www.type1diabetesresearch.org.uk/wp-content/uploads/2016/11/T1DUK-logo.pngsopnz2019-03-04 12:58:392021-08-25 14:03:12T1D UK Consortium Scientific and Clinical meetings at DUK 2019
Dear Colleagues, Our IDS congress committee has organized an outstanding scientific program for this year’s IDS meeting and coupled this to an exciting venue in the heart of London, UK.
Researchers with an interest in the immunology of diabetes and autoimmunity attended as well as those interested in gaining a greater understanding of the disease and the development of new therapeutic strategies. Talks from global experts covered a wide range of current topics of interest to the community, including ground-breaking technologies, cell-based and advanced therapeutics, immunopathology of type 1 diabetes and pathways to beta cell failure. There was lots of networking and discussion, with the shared hope of moving towards our common goal of understanding the immunology of type 1 diabetes and how we may intervene to change the course of disease.
https://type1diabetesresearch.org.uk/wp-content/uploads/2018/11/Idsphoto_800x600.jpg600800sopnzhttp://www.type1diabetesresearch.org.uk/wp-content/uploads/2016/11/T1DUK-logo.pngsopnz2018-11-09 10:08:102021-08-25 14:03:14Immunology of Diabetes Society Congress, 2018
BSI in collaboration with the T1D UK research consortium and the Immunology of Diabetes Society organised a “taster” day of research in Type 1 diabetes with national and international experts including:
Professor Colin Dayan, Chair – T1D UK Immunotherapy Research Consortium, Cardiff University
Professor Susan Wong, Cardiff University
Professor Mark Peakman, King’s College London
Professor Tim Tree, Lead – Mechanistic Core T1D UK Immunotherapy Research Consortium, King’s College London
The event took place 25th October 2018 at the QEII conference centre in Westminster, London and gave young scientists the chance to meet the lab leaders in this area and explore future career opportunities.
https://type1diabetesresearch.org.uk/wp-content/uploads/2018/10/5.jpg320240sopnzhttp://www.type1diabetesresearch.org.uk/wp-content/uploads/2016/11/T1DUK-logo.pngsopnz2018-11-02 13:35:032021-08-25 14:03:17Young Scientist Training in the Immunology of Diabetes
https://type1diabetesresearch.org.uk/wp-content/uploads/2018/01/Doctor-in-lab-Fun-Liu-e1516790818853.jpg439850sopnzhttp://www.type1diabetesresearch.org.uk/wp-content/uploads/2016/11/T1DUK-logo.pngsopnz2018-01-24 10:44:462021-08-25 14:03:19Multi-peptide Trial Aims to ‘Stall’ Type 1 Diabetes
https://type1diabetesresearch.org.uk/wp-content/uploads/2018/01/1st-injection-being-administered.jpg12001600sopnzhttp://www.type1diabetesresearch.org.uk/wp-content/uploads/2016/11/T1DUK-logo.pngsopnz2018-01-23 16:30:412021-08-25 14:03:19Pioneering Research for Type 1 Diabetes
We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
Google Analytics Cookies
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.
If you do not want that we track your visit to our site you can disable tracking in your browser here:
Other external services
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
Other cookies
The following cookies are also needed - You can choose if you want to allow them:
Privacy Policy
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.
Mahn’s story: taking part in immunotherapy research
An 11 year old’s story of taking part in immunotherapy research: Mahn was diagnosed with type 1 diabetes in May 2020. His parents Sharon and Harj were determined to get him onto a clinical trial testing a new treatment called immunotherapy, which hopes to slow the immune attack behind type 1 diabetes. Please click the link to Mahn’s story where he shares his experience of his diagnosis, treatments and life with diabetes.
Visit the full story here >
Type 1 Diabetes Breakthrough
Scientists and researchers are hoping to slow down the progression or prevent type one diabetes with immunotherapy treatments. This thought-provoking article from DUK’s Balance magazine explains how immunotherapy can help fight type 1 diabetes.
Delaying type 1 diabetes: an exciting breakthrough has been made by scientists in the trial of an immunotherapy drug that has been shown to delay a diagnosis of type 1 diabetes.
Preserving Insulin production in people with newly diagnosed type 1 diabetes: progress made with drug aiming to boost insulin production in newly diagnosed type 1’s.
T1D UK Consortium Scientific and Clinical meetings at DUK 2019
We have two exciting agendas lined up for our Consortium meetings being held at the DUK conference in Liverpool on 5th and 6th March.
All scientists from the Consortium are getting together on 5th March for an interesting day of reporting developments in type 1 diabetes research in the UK.
On Wednesday evening the annual meeting for all Consortium sites that recruit patients into clinical trials will take place. This will include representatives from the pharmaceutical industry and is a great opportunity for our researchers to join together and reflect on achievements and plan for future trials.
Immunology of Diabetes Society Congress, 2018
Dear Colleagues, Our IDS congress committee has organized an outstanding scientific program for this year’s IDS meeting and coupled this to an exciting venue in the heart of London, UK.
Researchers with an interest in the immunology of diabetes and autoimmunity attended as well as those interested in gaining a greater understanding of the disease and the development of new therapeutic strategies. Talks from global experts covered a wide range of current topics of interest to the community, including ground-breaking technologies, cell-based and advanced therapeutics, immunopathology of type 1 diabetes and pathways to beta cell failure. There was lots of networking and discussion, with the shared hope of moving towards our common goal of understanding the immunology of type 1 diabetes and how we may intervene to change the course of disease.
Related Links
Immunology of Diabetes Society Congress 2018
Young Scientist Training in the Immunology of Diabetes
BSI in collaboration with the T1D UK research consortium and the Immunology of Diabetes Society organised a “taster” day of research in Type 1 diabetes with national and international experts including:
The event took place 25th October 2018 at the QEII conference centre in Westminster, London and gave young scientists the chance to meet the lab leaders in this area and explore future career opportunities.
Multi-peptide Trial Aims to ‘Stall’ Type 1 Diabetes
Researchers at King’s College London and Guy’s and St Thomas’ hospital look into the possibility of slowing the progression of type 1 diabetes.
Link to news article with video: http://www.bbc.co.uk/news/health-35847271
Pioneering Research for Type 1 Diabetes
MonoPepT1De clinical trial for type 1 diabetes treatment shows promising results.
Link to news article: http://www.bbc.co.uk/news/health-40876438
Link to publication of results: http://stm.sciencemag.org/content/9/402/eaaf7779.full